UroGen Pharma Ltd. (URGN) Fell -6.72% or -3.65 To Price $50.65 On Friday


UroGen Pharma Ltd. (URGN) fell -6.72% or -3.65 to $50.65. It is about 49383 shares traded, which is 45.0% compare to the average total volume 109746. The market cap of URGN is $696.51 million. The year to date change is 40.53%. The 52 week price range is from $13.01 to $58.66. Price of URGN have changed 0.20% during last week. It have changed 8.60% over last month, 40.93% over last 3 months, 70.11% over last 6 months N/A

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for URGN is 50.84. It is 0.38% above current price. The stock faces resistance at 50-day moving averages. The 200-day Moving Averages for URGN is 33.60. It is -33.66% below current price. The 52-week High is 58.66. It is 15.81% from the current price. The 52-week Low is 13.01. It is -74.31% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of URGN is 1.09 on 2018-02-28. Short % to float is 0.98%. There are some statistics of URGN. It is has market cap $696.51 million. The share outstanding is 13.75 million. The average volume is 109746. The percent of top 15 Institution holding is 35.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of URGN is -49.11%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of URGN is -42.24%.


Tags:

Share this post